Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-25-000216
Filing Date
2025-02-27
Accepted
2025-02-27 16:05:32
Documents
95
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cldx-20241231x10k.htm   iXBRL 10-K 2490422
2 EX-10.12 cldx-20241231xex10d12.htm EX-10.12 36210
3 EX-10.17 cldx-20241231xex10d17.htm EX-10.17 28737
4 EX-19.1 cldx-20241231xex19d1.htm EX-19.1 47409
5 EX-21.1 cldx-20241231xex21d1.htm EX-21.1 3823
6 EX-23.1 cldx-20241231xex23d1.htm EX-23.1 2223
7 EX-31.1 cldx-20241231xex31d1.htm EX-31.1 10568
8 EX-31.2 cldx-20241231xex31d2.htm EX-31.2 10540
9 EX-32 cldx-20241231xex32.htm EX-32 7833
10 GRAPHIC cldx-20241231x10k002.jpg GRAPHIC 27875
  Complete submission text file 0001410578-25-000216.txt   9188778

Data Files

Seq Description Document Type Size
11 EX-101.SCH cldx-20241231.xsd EX-101.SCH 54104
12 EX-101.CAL cldx-20241231_cal.xml EX-101.CAL 62964
13 EX-101.DEF cldx-20241231_def.xml EX-101.DEF 210168
14 EX-101.LAB cldx-20241231_lab.xml EX-101.LAB 532116
15 EX-101.PRE cldx-20241231_pre.xml EX-101.PRE 385117
98 EXTRACTED XBRL INSTANCE DOCUMENT cldx-20241231x10k_htm.xml XML 1414815
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 25678667
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)